Search results
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 weeks agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 weeks agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - ...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via Yahoo Finance· 1 week agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 weeks agoModerna’s Spikevax vaccine was the third jab to be approved for use in the UK in January 2021 after...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology By Reuters
Investing.com· 2 weeks agoGSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 2 weeks agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends GSK and Moderna. The Motley Fool ...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 4 days agoModerna stock analysts project $4.19 billion in full-year revenue, including $4.06 billion in sales...
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 7 days agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 4 days agoModerna anticipates offering a respiratory syncytial virus vaccine later this year, to compete...
